One especially frightening type of cancer that is extremely difficult to detect and seems to show up more often in Black ...

Shakeya Allen was 27 years old when she felt something was not right with her health. A miscarriage would lead to her diagnosis. “They said, ‘Don’t worry. Women under 40 do not get uterine cancer.

I don’t want to get too real here, but recently a series of bad things has happened and one of them was potential uterine ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

Discover the role of phytoestrogens, including soy, in menopause management and breast cancer prevention. Learn how these ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.

Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...

The in-house salon for patients at Roswell Park will now be called the New Era Cap Foundation Elevate Salon. BUFFALO, N.Y. — ...

Introduction: Women with low-risk endometrial cancer, as defined by the Korean Gynecologic Oncology Group (KGOG) criteria, have a low risk of lymph node metastasis and an excellent prognosis without ...